The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia
Draptchinskaia, N., Gustavsson, P., Andersson, B., Pettersson, M., Willig, T.-N., Dianzani, I., Ball, S., Tchernia, G., Klar, J., Matsson, H., et al. (1999) · Nature Genetics · doi:10.1038/5951 · Cited by 795
The genetics and pathology of oxidative phosphorylation
Smeitink, J., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 724
Perucca, E. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00004 · Cited by 690
Khorasanizadeh, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00044-3 · Cited by 674
L??scher, W. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00003 · Cited by 664
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614
ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma
Frank, N. Y., Margaryan, A., Huang, Y., Schatton, T., Waaga-Gasser, A. M., Gasser, M., Sayegh, M. H., Sadee, W., & Frank, M. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3327 · Cited by 574
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
Gurvich, N., Tsygankova, O. M., Meinkoth, J. L., & Klein, P. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0799 · Cited by 459
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Cornacchia, E., Golbus, J., Maybaum, J., Strahler, J., Hanash, S., & Richardson, B. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2197 · Cited by 420
Many Ribosomal Protein Genes Are Cancer Genes in Zebrafish
Amsterdam, A., Sadler, K. C., Lai, K., Farrington, S., Bronson, R. T., Lees, J. A., & Hopkins, N. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020139 · Cited by 417
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., & Curry, C. J. R. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190308 · Cited by 399
Valproate: Past, Present, and Future
Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
Expression profile of class I histone deacetylases in human cancer tissues
Nakagawa, M., Oda, Y., Eguchi, T., Aishima, S.-I., Yao, T., Hosoi, F., Basaki, Y., Ono, M., Kuwano, M., Tanaka, M., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.769 · Cited by 341
Deng, C., Lu, Q., Zhang, Z., Rao, T., Attwood, J., Yung, R., & Richardson, B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10833 · Cited by 284
Klenova, E. M., Morse, H. C., Ohlsson, R., & Lobanenkov, V. V. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00060-3 · Cited by 276
Differential expression of selected histone modifier genes in human solid cancers
Özdağ, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G., Subkhankulova, T., Arends, M. J., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-90 · Cited by 259
Candelaria, M., Gallardo-Rincón, D., Arce, C., Cetina, L., Aguilar-Ponce, J. L., Arrieta, Ó., González-Fierro, A., Chávez-Blanco, A., de la Cruz-Hernández, E., Camargo, M. F., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm204 · Cited by 252
Self-citation[Pharmacodynamic properties of N-dipropylacetic acid].
Meunier, H., Carraz, G., Neunier, Y., Eymard, P., & Aimard, M. (1963) · PubMed · Cited by 251
Epigenetics as a mechanism driving polygenic clinical drug resistance
Glasspool, R. M., Teodoridis, J. M., & Brown, R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603024 · Cited by 236
Teratogenicity of sodium valproate
Alsdorf, R., & Wyszynski, D. F. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.2.345 · Cited by 236
Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells
Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I., & Koeffler, H. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0100 · Cited by 233
Epigenetics of cervical cancer. An overview and therapeutic perspectives
Dueñas-González, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C., & Cervera, E. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-38 · Cited by 231
Self-citationDNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.
Zhu, W., Lakshmanan, R. R., Beal, M. D., & Otterson, G. A. (2001) · PubMed · Cited by 226
Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice
Parulekar, W. R., & Eisenhauer, E. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh182 · Cited by 223
Münster, P., Marchion, D., Bicaku, E., Schmitt, M., Lee, J. H., DeConti, R., Simon, G., Fishman, M., Minton, S., Garrett, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6165 · Cited by 216
Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
Marchion, D. C., Bicaku, E., Daud, A. I., Sullivan, D. M., & Munster, P. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2478 · Cited by 212
Segura-Pacheco, B. A., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Mariscal, I., Chavez, A., Acuña, C., Salazar, A. M., Lizano, M., & Dueñas‐González, A. (2003) · PubMed · Cited by 206
Huang, G., Lu, H., Hao, A., Ng, D. C. H., Ponniah, S., Guo, K., Lufei, C., Zeng, Q., & Cao, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8447-8456.2004 · Cited by 202
Li, X.-N., Shu, Q., Su, J. M.-F., Perlaky, L., Blaney, S. M., & Lau, C. C. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0184 · Cited by 201
Covalent modifications of histones: expression from chromatin templates
Davie, J. R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80138-x · Cited by 199
Atmaca, A., Al-Batran, S.-E., Maurer, A., Neumann, A., Heinzel, T., Hentsch, B., Schwarz, S. E., Hövelmann, S., Göttlicher, M., Knuth, A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603851 · Cited by 183
Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer
Pruitt, S. C., Bailey, K. J., & Freeland, A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0483 · Cited by 172
Characterization of a novel metabolic strategy used by drug‐resistant tumor cells
Harper, M., Antoniou, A., Villalobos‐Menuey, E., Russo, A., Trauger, R., Vendemelio, M., George, A., Bartholomew, R., Carlo, D., Shaikh, A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0541com · Cited by 172
Hrzenjak, A., Moinfar, F., Kremser, M.-L., Strohmeier, B., Staber, P. B., Zatloukal, K., & Denk, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0480 · Cited by 163
Zambrano, P., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Cetina, L., Vázquez, A. L. R., Taja‐Chayeb, L., Chávez-Blanco, A. D., Ángeles, E., Cabrera, G., Sandoval, K., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-44 · Cited by 156
Development of histone deacetylase inhibitors for cancer treatment
Marchion, D. C., & Münster, P. N. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.583 · Cited by 155
Dannenberg, L. O., & Edenberg, H. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-181 · Cited by 148
Arce, C., Pérez‐Plasencia, C., González‐Fierro, A., la Cruz-Hernández, E. N. D., Vázquez, A. L. R., Chávez-Blanco, A. D., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Bargalló, E., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000098 · Cited by 146
Self-citationGreenblatt, D. Y., Vaccaro, A. M., Jaskula‐Sztul, R., Li, N., Haymart, M. R., Kunnimalaiyaan, M., & Chen, H. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-942 · Cited by 145
Valproic acid for the treatment of myeloid malignancies
Kuendgen, A., & Gattermann, N. (2007) · Cancer · doi:10.1002/cncr.22891 · Cited by 143
Chávez-Blanco, A. D., Pérez‐Plasencia, C., Pérez‐Cárdenas, E., Legleu, C. E. C., Rangel‐López, E., Segura-Pacheco, B. A., Taja‐Chayeb, L., Trejo‐Becerril, C., González‐Fierro, A., Candelaria, M., et al. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-2 · Cited by 143
Self-citationKlisovic, M. I., Maghraby, E. A., Parthun, M. R., Guimond, M., Sklenar, A. R., Whitman, S. P., Chan, K. K. L., Murphy, T., Anon, J., Archer, K. J., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402776 · Cited by 142
Shi, H., Wei, S. H., Leu, Y., Rahmatpanah, F. B., Liu, J. C., Yan, P. S., Nephew, K. P., & Huang, T. H. ‐. (2003) · PubMed · Cited by 136
Lipton, J. M. M., Federman, N. C., Khabbaze, Y., Schwartz, C. L., Hilliard, L., Clark, J. I., & Vlachos, A. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200101000-00009 · Cited by 134
Histone deacetylase inhibitors: gathering pace
CAREY, N., & Thangue, N. B. L. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.010 · Cited by 130
Valproic Acid Induces Apoptosis and Cell Cycle Arrest in Poorly Differentiated Thyroid Cancer Cells
Catalano, M. G., Fortunati, N., Pugliese, M., Costantino, L., Poli, R., Bosco, O., & Boccuzzi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1355 · Cited by 130
Chávez-Blanco, A. D., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Cetina, L., Candelaria, M., de León, D. F. C., González‐Fierro, A., García‐López, P., Zambrano, P., et al. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-22 · Cited by 129
Self-citationThe role of translation in neoplastic transformation from a pathologist's point of view
Rosenwald, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207552 · Cited by 125
Feng, W., & Kenney, S. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1006 · Cited by 124
Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo
Xia, Q., Sung, J., Chowdhury, W. H., Chen, C., Höti, N., Shabbeer, S., Carducci, M. A., & Rodríguez, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0487 · Cited by 123
Catalano, M. G., Fortunati, N., Pugliese, M., Poli, R., Bosco, O., Mastrocola, R., Aragno, M., & Boccuzzi, G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06970 · Cited by 121
Pathil, A., Armeanu, S., Venturelli, S., Mascagni, P., Weiß, T. S., Gregor, M., Lauer, U. M., & Bitzer, M. (2006) · Hepatology · doi:10.1002/hep.21054 · Cited by 121
Hydralazine target: From blood vessels to the epigenome
Arce, C., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Candelaria, M., & Dueñnas-Gonzalez, A. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-10 · Cited by 119
Self-citationTakai, N., Kawamata, N., Gui, D., SAID, J. W., Miyakawa, I., & Koeffler, H. P. (2004) · Cancer · doi:10.1002/cncr.20709 · Cited by 119
Bovenzi, V., & Momparler, R. L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100294 · Cited by 118
Rodríguez‐Enríquez, S., Vital‐González, P. A., Flores‐Rodríguez, F. L., Marín‐Hernández, Á., Ruíz-Azuara, L., & Moreno‐Sánchez, R. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.02.005 · Cited by 116
Depletion of yeast ribosomal proteins L16 or rp59 disrupts ribosome assembly.
Moritz, M., Paulovich, A. G., Tsay, Y., et al. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.2261 · Cited by 114
Chang, S., & Pikaard, C. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409053200 · Cited by 113
Hodges-Gallagher, L., Valentine, C. D., Bader, S. E., & Kushner, P. J. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9459-6 · Cited by 108
Tomiyama, A., Serizawa, S., Tachibana, K., Sakurada, K., Samejima, H., Kuchino, Y., & Kitanaka, C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj395 · Cited by 107
Chen, J., Ghazawi, F. M., Bakkar, W., & Li, Q. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-71 · Cited by 106
Das, C. M., Aguilera, D. G., Vasquez, H., Prasad, P., Zhang, M., Wolff, J. E. A., & Gopalakrishnan, V. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9402-7 · Cited by 102
Dose escalation trial designs based on a molecularly targeted endpoint
Hunsberger, S., Rubinstein, L., Dancey, J. E., & Korn, E. L. (2005) · Statistics in Medicine · doi:10.1002/sim.2102 · Cited by 99
Rodins, K., Cheale, M., Coleman, N., & Fox, S. B. (2002) · PubMed · Cited by 95
Fortunati, N., Catalano, M. G., Arena, K., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031407 · Cited by 92
Gazda, H. T., Kho, A. T., Sanoudou, D., Zaucha, J. M., Kohane, I. S., Sieff, C. A., & Beggs, A. H. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0554 · Cited by 88
Antitumor activity of sodium valproate in cultures of human neuroblastoma cells
Cínatl, J., Činátl, J., Scholz, M., et al. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199609000-00008 · Cited by 88
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast
Shetty, A., Loddo, M., Fanshawe, T. R., Prevost, A. T., Sainsbury, R., Williams, G. H., & Stoeber, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602829 · Cited by 87
Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid
Isenberg, J. S., Jia, Y., Field, L., Ridnour, L. A., Sparatore, A., Soldato, P. D., Sowers, A. L., Yeh, G. C., Moody, T. W., Wink, D. A., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707198 · Cited by 86
Structure and dynamic properties of nucleosome core particles
Chakravarthy, S., Park, Y., Chodaparambil, J. V., Edayathumangalam, R. S., & Luger, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.030 · Cited by 85
Activation of the c-ski oncogene by overexpression
Colmenares, C., Sutrave, P., Hughes, S. H., & Stavnezer, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4929-4935.1991 · Cited by 84
Primeau, M., Gagnon, J., & Momparler, R. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10789 · Cited by 82
Shabbeer, S., Kortenhorst, M. S. Q., Kachhap, S. K., Galloway, N. L., Rodriguez, R., & Carducci, M. A. (2007) · The Prostate · doi:10.1002/pros.20587 · Cited by 80
Yong, H., & Moon, A. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977781 · Cited by 80
Schuchmann, M., Schulze‐Bergkamen, H., Fleischer, B., Schattenberg, J. M., Siebler, J., Weinmann, A., Teufel, A., Wörns, M., Fischer, T., Strand, S., et al. (2006) · Oncology Reports · doi:10.3892/or.15.1.227 · Cited by 77
In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates
Marchion, D. C., Biçaku, E., DAUD, A. I., Sullivan, D. M., & Münster, P. N. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0194 · Cited by 74
Mora‐García, M. D. L., Dueñas‐González, A., Hernández‐Montes, J., la Cruz-Hernández, E. N. D., Pérez‐Cárdenas, E., Weiss‐Steider, B., Santiago‐Osorio, E., Ortiz-Navarrete, V. F., Rosales, V. H., de León, D. F. C., et al. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-55 · Cited by 72
Thelen, P., Schweyer, S., Hemmerlein, B., Wuttke, W., Seseke, F., & Ringert, R.-H. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.25 · Cited by 71
la Cruz-Hernández, E. N. D., Pérez‐Cárdenas, E., Contreras‐Paredes, A., de León, D. F. C., Mohar, A., Lizano, M., & Dueñas‐González, A. (2007) · Virology Journal · doi:10.1186/1743-422x-4-18 · Cited by 70
Mongan, N. P., & Gudas, L. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0079 · Cited by 70
Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin
Regan, C. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90207-0 · Cited by 67
Modulation of angiogenesis-related protein synthesis by valproic acid
Zgouras, D., Becker, U., Loitsch, S. M., & Stein, J. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.105 · Cited by 65
Nontoxicity Endpoints in Phase I Trial Designs for Targeted, Non-Cytotoxic Agents
Korn, E. L. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh208 · Cited by 65
NA+‐ and K+‐channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres
Friedrich, O., von Wegner, F., Wink, M., & Fink, R. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707194 · Cited by 61
Shen, W. T., Wong, T. S., Chung, W.-Y., Wong, M. G., Kebebew, E., Duh, Q., & Clark, O. H. (2005) · Surgery · doi:10.1016/j.surg.2005.09.019 · Cited by 59
Dynamic chromatin: concerted nucleosome remodelling and acetylation
Eberharter, A., Ferreira, R., & Becker, P. B. (2005) · Biological Chemistry · doi:10.1515/bc.2005.087 · Cited by 59
Huang, X., & Guo, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0887 · Cited by 57
Knüpfer, M. M., Driever, P. H., Poppenborg, H., Wolff, J. E. A., & Cinatl, J. J. (1998) · PubMed · Cited by 52
Ziauddin, M. F., Yeow, W.-S., Maxhimer, J. B., Baras, A., Chua, A., Reddy, R. M., Tsai, W. S., Cole, G. W., Schrump, D. S., & Nguyen, D. M. (2006) · Neoplasia · doi:10.1593/neo.05823 · Cited by 49
Gagnon, J., Shaker, S., Primeau, M., Hurtubise, A., & Momparler, R. L. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200303000-00002 · Cited by 46
Michaelis, M., Suhan, T. O., Činátl, J., Driever, P. H., & Cinatl, J. J. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1795 · Cited by 45
Valentini, A., Biancolella, M., Amati, F., Gravina, P., Miano, R., Chillemi, G., Farcomeni, A., Bueno, S., Vespasiani, G., Desideri, A., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014662 · Cited by 45
Valproic Acid Inhibits Invasiveness in Bladder Cancer but Not in Prostate Cancer Cells
Chen, C., Sung, J., Cohen, M. J., Chowdhury, W. H., Sachs, M. D., Li, Y., Lakshmanan, Y., Yung, B. Y., Lupold, S. E., & Rodríguez, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106658 · Cited by 45
Genes, Chromatin, and Breast Cancer: An Epigenetic Tale
Mielnicki, L. M., Asch, H. L., & Asch, B. B. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011356623442 · Cited by 44
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Pérez‐Plasencia, C., & Dueñas‐González, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-27 · Cited by 41
Mamelak, A. J., Kowalski, J., Murphy, K. M., Yadava, N., ZAHURAK, M. L., Kouba, D. J., Howell, B. G., Tzu, J., Cummins, D. L., Liégeois, N. J., et al. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00278.x · Cited by 37
Addition of Histone Deacetylase Inhibitors in Combination Therapy
Carraway, H. E., & Gore, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8293 · Cited by 29
Karpf, A. R. (2007) · PubMed · Cited by 29
Friedmann, I., Atmaca, A., Chow, K. U., Jäger, E., & Weidmann, E. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.4.415 · Cited by 25
(1998) · doi:10.1002/(sici)1521-1878(199808)20:8<615::aid-bies4>3.0.co;2-h
Cited by
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Chateauvieux, S., Morceau, F., Dicato, M., & Diederich, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/479364 · Cited by 512
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 428
Zhao, L., Chen, C.-N., Hajji, N., Oliver, E., Cotroneo, E., Wharton, J., Wang, D., Li, M., McKinsey, T. A., Stenmark, K. R., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.103176 · Cited by 259
Metadata
- Authors
- Duenas-Gonzalez, A., Candelaria, M., Perez-Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E., & Herrera, L. A.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 34
- Issue
- 3
- Pages
- 206-222
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W1984025642
- Cited by
- 354
- References
- 112
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.